Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery

Name: Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery
Published: 2012
License: Public Domain

National Cancer Institute (NCI) · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

recurrent renal cell carcinoma, stage iii renal cell cancer, stage iv renal cell cancer, type 1 papillary renal cell carcinoma, type 2 papillary renal cell carcinoma, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery

Related documents